These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11169936)

  • 1. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies.
    Airoldi M; Pedani F; Succo G; Gabriele AM; Ragona R; Marchionatti S; Bumma C
    Cancer; 2001 Feb; 91(3):541-7. PubMed ID: 11169936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.
    Hong MH; Kim CG; Koh YW; Choi EC; Kim J; Yoon SO; Kim HR; Cho BC
    Head Neck; 2018 Jan; 40(1):55-62. PubMed ID: 29044862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases.
    Airoldi M; Garzaro M; Pedani F; Ostellino O; Succo G; Riva G; Sensini M; Naqe N; Bellini E; Raimondo L; Pecorari G
    Am J Clin Oncol; 2017 Feb; 40(1):86-90. PubMed ID: 25089531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
    Vici P; Colucci G; Giotta F; Sergi D; Filippelli G; Perri P; Botti C; Vizza E; Carpino A; Pizzuti L; Latorre A; Giannarelli D; Lopez M; Di Lauro L
    J Exp Clin Cancer Res; 2011 Apr; 30(1):39. PubMed ID: 21481280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
    Saeki T; Takashima S; Ogita M; Tabei T; Adachi I; Tamura K; Takatsuka Y; Kanda K
    Breast Cancer; 2006; 13(2):159-65. PubMed ID: 16755111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix.
    Gebbia V; Caruso M; Testa A; Mauceri G; Borsellino N; Chiarenza M; Pizzardi N; Palmeri S
    Oncology; 2002; 63(1):31-7. PubMed ID: 12187068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.
    Gebbia V; Testa A; Borsellino N; Ferrera P; Tirrito M; Palmeri S
    Ann Oncol; 2001 Jun; 12(6):767-72. PubMed ID: 11484950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinorelbine treatment of recurrent salivary gland carcinomas.
    Airoldi M; Bumma C; Bertetto O; Gabriele P; Succo G; Pedani F
    Bull Cancer; 1998 Oct; 85(10):892-4. PubMed ID: 9835866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
    Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Harpidou A; Kalbakis K; Rapti A; Androulakis N; Sarra E; Georgoulias V; Papadakis E
    Oncology; 2001; 60(3):235-41. PubMed ID: 11340375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
    Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
    Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
    Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
    Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
    Kelly K; Crowley J; Bunn PA; Presant CA; Grevstad PK; Moinpour CM; Ramsey SD; Wozniak AJ; Weiss GR; Moore DF; Israel VK; Livingston RB; Gandara DR
    J Clin Oncol; 2001 Jul; 19(13):3210-8. PubMed ID: 11432888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.
    Conroy T; Etienne PL; Adenis A; Ducreux M; Paillot B; Oliveira J; Seitz JF; Francois E; Van Cutsem E; Wagener DJ; Kohser F; Daamen S; Praet M; Gorlia T; Baron B; Wils J;
    Ann Oncol; 2002 May; 13(5):721-9. PubMed ID: 12075740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
    Wozniak AJ; Crowley JJ; Balcerzak SP; Weiss GR; Spiridonidis CH; Baker LH; Albain KS; Kelly K; Taylor SA; Gandara DR; Livingston RB
    J Clin Oncol; 1998 Jul; 16(7):2459-65. PubMed ID: 9667264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.